mechlorethamine hydrochloride
Sponsors
European Organisation for Research and Treatment of Cancer - EORTC, M.D. Anderson Cancer Center, Stanford University, Centro di Riferimento Oncologico - Aviano, Mount Vernon Cancer Centre at Mount Vernon Hospital
Conditions
Brain and Central Nervous System TumorsLymphoma
Phase 2
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
CompletedNCT00002715
Start: 1989-04-30End: 2015-10-31Target: 50Updated: 2020-08-12
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
NCT00003262
Start: 1997-05-31Target: 30Updated: 2013-09-20
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
CompletedNCT00002714
Start: 1995-04-30End: 2001-09-30Updated: 2013-05-15
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
CompletedNCT00002463
Start: 1989-02-28End: 2008-01-31Updated: 2013-02-18
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
CompletedNCT00574496
Start: 2007-11-13End: 2022-08-02Updated: 2023-09-28
Phase 3
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
NCT00041210
Start: 2001-10-31Target: 850Updated: 2013-09-20
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
Active, not recruitingNCT00002462
Start: 1989-09-30Updated: 2025-08-05
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
Active, not recruitingNCT00379041
Start: 1993-09-01Target: 1158Updated: 2025-08-05